View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AB55 Publication ID: Spring 2022 
Title: Implementation of the SUPPORT Act: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment 
Abstract:

This rulemaking will update the DEA’s regulations to implement the provisions of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 expanding the range of practitioners eligible to prescribe FDA-approved medications for the treatment of opioid use disorder and modifying provisions governing the delivery of a controlled substance by a pharmacy to a practitioner.

 
Agency: Department of Justice(DOJ)  Priority: Economically Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: Yes  Unfunded Mandates: No 
CFR Citation: 21 CFR 1301.28    21 CFR 1306.04    21 CFR 1306.07   
Legal Authority: Pub. L. 115-271   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Interim Final Rule  11/02/2020  85 FR 69153   
Interim Final Rule Effective  10/30/2020 
Interim Final Rule Comment Period End  01/04/2021 
Final Action  07/00/2022 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Federalism: No 
Included in the Regulatory Plan: No 
RIN Information URL: https://www.regulations.gov/  
RIN Data Printed in the FR: No 
Agency Contact:
Scott A. Brinks
Section Chief, Regulatory Drafting and Support Section, Diversion Control Division
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Springfield, VA 22152
Phone:571 362-8209
Email: scott.a.brinks@dea.gov